Indication

Cytomegalovirus retinitis

Cytomegalovirus retinitis is a sight-threatening opportunistic viral infection of the retina caused by the reactivation or primary infection of cytomegalovirus, a beta-herpesvirus. Read more about Cytomegalovirus retinitis

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Cytomegalovirus retinitis therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Cytomegalovirus retinitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cytomegalovirus retinitis.

Cytomegalovirus retinitis is a sight-threatening opportunistic viral infection of the retina caused by the reactivation or primary infection of cytomegalovirus, a beta-herpesvirus.

It predominantly affects severely immunocompromised individuals, most notably patients with advanced acquired immunodeficiency syndrome (AIDS), particularly those with CD4+ T-lymphocyte counts below 50 cells/mm³, as well as organ transplant recipients and individuals undergoing profound immunosuppressive chemotherapy.

Pathophysiologically, the virus infects retinal cells and vascular endothelial cells, producing full-thickness necrotizing retinitis characterized clinically by expanding granular, white-to-yellow retinal infiltrates often accompanied by extensive intraretinal hemorrhages and vasculitis.

Without prompt intervention, this progressive retinal destruction frequently leads to retinal detachment, optic atrophy, and irreversible blindness.

Personalize your experience

Follow Cytomegalovirus retinitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it